Companies

Explore all the available companies. Are you wondering how to find wonderful businesses at great price? Start from A... or take a look at Compoundeer Ranking.

  1. Abrdn Emerging Markets Equity Income Fund, Inc.

    The Fund seeks to provide both current income and longterm capital appreciation. The fund invests primarily in Chilean equity & debt securities. It is the policy of the Fund normally to invest at least 80% of total assets both in Chilean equity and debt securities, although under normal market conditions most investments will be in equity securities.

    AEF
  2. Abrdn Global Dynamic Dividend Fund

    Alpine Global Dynamic Dividend Fund is a United States based diversified closedend management investment company.

    AGD
  3. Abrdn Global Income Fund, Inc.

    The Funds principal investment objective is to provide high current income by investing primarily in fixedincome securities. As a secondary investment objective the Fund seeks capital appreciation but only when consistent with its principal investment objective.

    FCO
  4. Abrdn Global Infrastructure Income Fund

    Aberdeen Standard Global Infrastructure Income Fund (the Fund) is a newly organized, non-diversified, closed-end management investment company. The Funds investment objective is to seek to provide a high level of total return with an emphasis on current income. There is no assurance that the Fund will achieve its investment objective The Fund seeks to achieve its investment objective by investing in a portfolio of income-producing public and private infrastructure equity investments around the world. Under normal circumstances, at least 80% of the Funds net assets (plus the amount of any borrowings for investment purposes) will be invested in U.S. and non-U.S. infrastructure-related issuers.

    ASGI
  5. Abrdn Global Premier Properties Fund

    The Funds primary investment objective is to seek capital appreciation with secondary objective of high current income.

    AWP
  6. Abrdn Gold Etf Trust

    No description

    SGOL
  7. Abrdn Healthcare Investors

    Tekla Healthcare Investors is a United States based nondiversified closedend management investment company. Its objective is to seek longterm capital appreciation by investing primarily in securities of healthcare companies.

    HQH
  8. Abrdn Healthcare Opportunities Fund

    Tekla Healthcare Opportunities Fund is a nondiversified closedend fund. The funds objective is to seek current income and longterm capital appreciation through investing in companies engaged in the healthcare industry.

    THQ
  9. Abrdn Income Credit Strategies Fund

    The Funds primary investment objective is to seek a high level of current income with a secondary objective ofcapital appreciation.

    ACP
  10. Abrdn Japan Equity Fund, Inc.

    Aberdeen Japan Equity Fund Inc is a United States based closed-end diversified management investment company. Its investment objective is to outperform over the long term, on a total return basis.

    JEQ
  11. Abrdn Life Sciences Investors

    Tekla Life Sciences Investors is a United States based closedend management investment company. Its investment objective is to seek longterm capital appreciation by investing primarily in the securities of life sciences companies.

    HQL
  12. Abrdn National Municipal Income Fund

    Delaware Investments Natl Muni Income is a closed-end investment fund.

    VFL
  13. Abrdn Palladium Etf Trust

    No description

    PALL
  14. Abrdn Platinum Etf Trust

    No description

    PPLT
  15. Abrdn Precious Metals Basket Etf Trust

    No description

    GLTR
  16. Abrdn Silver Etf Trust

    No description

    SIVR
  17. Abrdn Total Dynamic Dividend Fund

    Alpine Total Dynamic Dividend Fund is a diversified closedend management investment company. Its investment objective is to seek high current dividend income and also focuses on longterm growth of capital.

    AOD
  18. Abrdn World Healthcare Fund

    Tekla World Healthcare Fund is a closed end fund. Its objective is to provide a high level of current income and longterm capital appreciation. Trust expects to invest at least 80% of its Managed Assets in U.S. and non-U.S. companies engaged in the healthcare industries including equity securities and debt securities. Managed Assets means the total assets of the Trust minus the sum of the Trusts accrued liabilities. The Trusts 80% policy may only be changed with 60 days prior notice to the Trusts shareholders. The Trust will concentrate its investments in the healthcare industries. No assurance can be given that the Trust will achieve its investment objective.

    THW
  19. Absci Corp

    Absci Corp is the Artificial intelligence powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. It enables the creation of novel biologics by unifying biologic drug discovery and cell line development into one simultaneous process.

    ABSI
  20. Abvc Biopharma, Inc.

    ABVC BioPharma licenses promising medical research conducted in the Asia-Pacific region and enlists top-ranked principal investigators in the United States to conduct Phase II clinical trials. We specialize in botanically based solutions that deliver high efficacy with low toxicity for improved health outcomes that represent enormous commercial potential.

    ABVC
  21. Ac Immune Sa

    AC Immune SA is a clinical-stage biopharmaceutical company that focuses on neurodegenerative diseases. The company uses its proprietary technology platforms to discover, design, and develop novel proprietary small molecules, antibodies, and vaccines for prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding.

    ACIU
  22. Ac Partners, Inc.

    AC Partners, Inc., headquartered in Palm City Florida, engages in the design, sale, maintenance and installation of central air conditioning systems for commercial and residential customers ACPI is an authorized dealership for Rheem, American Standard, Goodman and Amana air conditioning systems. ACPI's primary focus is to grow through strategic acquisitions and maximize our customers and partnerships.

    ACPS
  23. Acacia Research Corp

    Acacia Research Corp is engaged in the acquisition, development, and patents technologies through its subsidiaries. It assists patent owners with the prosecution and development of their patent portfolios; protection of their patented inventions from unauthorized use; generation of licensing revenue from users of their patented technologies; and enforcement against unauthorized users of their patented technologies.

    ACTG
  24. Academy Sports & Outdoors, Inc.

    Academy Sports and Outdoors Inc is engaged in the retail business of sporting goods and outdoor recreation products. The company offers outdoor clothing, backpacks, sunglasses, luggage items, shooting equipment, fishing equipment, boating and water sports equipment, backyard recreation products, outdoor cooking equipment, fitness equipment, electronic items, dog supplies, and other products.

    ASO
  25. Acadia Healthcare Company, Inc.

    Acadia Healthcare Co Inc acquires and develops behavioral healthcare facilities in the United States, United Kingdom, and Puerto Rico. Acute inpatient psychiatric facilities and specialty treatment facilities contribute the vast majority of Acadia's revenue in the United States. The U.S. facilities receive the largest proportion of payments from Medicaid, with the second- largest proportion from commercial payors. In the United Kingdom, the majority of Acadia's revenue comes from its healthcare facilities, and virtually all of the payment received is from the National Health Service.

    ACHC
  26. Acadia Pharmaceuticals Inc

    Acadia Pharmaceuticals is a biotechnology company that develops and commercializes biopharmaceutical products to address central nervous system disorders. The company aims to discover small molecule drugs that address disorders such as Parkinson's, Alzheimer's, and schizophrenia. Acadia also seeks to in-license or acquire complementary products and candidates. The company's patent applications claim proprietary technology, including novel methods of screening and chemical synthetic methods, novel drug targets, and novel compounds identified using its technology.

    ACAD
  27. Acadia Realty Trust

    Acadia Pharmaceuticals is a biotechnology company that develops and commercializes biopharmaceutical products to address central nervous system disorders. The company aims to discover small molecule drugs that address disorders such as Parkinson's, Alzheimer's, and schizophrenia. Acadia also seeks to in-license or acquire complementary products and candidates. The company's patent applications claim proprietary technology, including novel methods of screening and chemical synthetic methods, novel drug targets, and novel compounds identified using its technology.

    AKR
  28. Acap Strategic Fund

    No description

    XCAPX
  29. Acasti Pharma Inc.

    Grace Therapeutics, Inc. engages in the development and commercialization of pharmaceutical products for rare and orphan diseases in Canada. The company's lead product candidate is the GTX-104, an intravenous infusion to treat subarachnoid hemorrhage. It also develops GTX-102, an oral mucosal betamethasone spray for the treatment of ataxia-telangiectasia; and GTX-101, a topical bioadhesive film-forming bupivacaine spray for postherpetic neuralgia. The company was formerly known as Acasti Pharma Inc. and changed its name to Grace Therapeutics, Inc. in October 2024. The company was incorporated in 2002 and is headquartered in Princeton, New Jersey.

    GRCE
  30. Accel Entertainment, Inc.

    Accel Entertainment Inc is a distributed gaming operator in the United States. It is engaged in the installation, maintenance, and operation of video gaming terminals. The company offers products to restaurants, bars, taverns, convenience stores, liquor stores, truck stops, and grocery stores. It operates slot machines and amusement equipment. The company generates a majority of its revenue from video gaming.

    ACEL